3D Cell Culture: An Early-Stage Oncology Drug Discovery Tool

New testing methods are imperative at early stages of drug development to reduce the expensive, late-stage failures due to efficacy and safety. Drug testing data, particularly in oncology, from in vivo-mimicking 3D cell cultures have the potential to play a pivotal role in early-stage decision-making about the probability of therapeutic candidates’ success. This white paper demonstrates the capabilities of the Perfecta3D Hanging Drop Plates from 3D Biomatrix for spheroid growth and subsequent high-throughput testing of anti-cancer compounds at the preclinical discovery phase.